BKYI$2.27-7.35%
Bio Key International Inc.
Sector: Services-Prepackaged SoftwareIndustry: Information Technology ServicesCountry: USExchange: Nasdaq
Mkt Cap:$4.62M
Float & O/S:
Inst Own:
DilutionScan read 26 of BIO KEY INTERNATIONAL INC's SEC filings and found 8 warrant series, 3 S-1 registrations and 6 completed offerings on file for BKYI. The latest dilution event on file is a registration statement on Oct 9, 2026. Analysis updated Oct 30, 2026.
Signal8 Summary
BKYI
Going-concern warning, severe dilution overhang
Snapshot
BIO-key is a tiny identity-security micro-cap with $6.1M in FY 2025 revenue, down 12% YoY, though healthy 77.5% gross margin. It lost $4.6M for the year and burned $4.7M in free cash flow.
What's Happening Right Now
- : BIO-key filed an S-1 registering 1.24M warrant shares (about 38% of shares outstanding) for Armistice Capital; a prior stockholder vote to approve the warrants failed and the meeting was adjourned again to October 30, 2026.
- : Registered 1.24M shares for sale on Form S-1.
- : $416K principal converted · 247.8K shares.
- : Q2 2026 10-Q showed revenue up 13% YoY to $1.92M and a narrower net loss, but disclosed going-concern doubt with only $1.38M cash against roughly $750K in monthly operating needs.
- : Stockholders failed to approve the Nasdaq-required warrant issuance (Proposal 4) at the September 3, 2026 annual meeting, blocking the share issuance and leaving the Armistice inducement deal incomplete.
- : On August 10, 2026, BIO-key induced Armistice Capital to cash-exercise warrants by cutting the strike from $10.20 to $4.06, raising $2.51M, in exchange for new warrants on double the shares.
- : Raised $2.51M in gross proceeds through an offering, with warrants over 1.24M shares.
- : BIO-key was selected by the Central Bank of Jordan to support a national biometric authentication initiative across the country's financial sector.
